Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin Plus Pemetrexed in HIV+ NSCLC
NCT01296113Phase 2Completed
- Sponsor
- IFCT
- Start
- May 2011
- Primary completion
- Jan 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed, carboplatin in non-small cell lung cancer (NSCLC), sponsored by IFCT. Started May 2011; status: completed.
02
Drugs
pemetrexedcarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01296113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01296113.